UNSPSC 51371600: Controlled substance analgesic alcohols

Controlled substance analgesic drugs made from alkyl compounds containing a hydroxyl group.

UNSPSC 51371600 Controlled substance analgesic alcohols is a Class code describing pharmaceutical products and pain management supplies that state and local governments procure for public health, community health, and employee benefit programs. Recent solicitations show state and local bodies purchasing naloxone (opioid antagonist) units, over-the-counter pharmaceuticals, generic multi-source medications, and related drug deactivation systems to support emergency response, substance abuse prevention, and healthcare delivery. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP). The purchasing pattern reflects a mix of direct county procurement, state-level pharmacy benefit program sourcing, and cooperative purchasing arrangements that serve multiple participating jurisdictions.

Recent activity centers in Florida, Texas, Minnesota, and Oregon, with the most visible procurement action in cooperative purchasing vehicles. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries and a response deadline of July 26, 2023 (note: deadline date appears inconsistent with post date). The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor information on direct-to-manufacturer prescription fulfillment models before issuing a formal RFP; this represents early-stage market research rather than an immediate procurement. The Minnesota Department of Administration issued an RFP through MMCAP on January 20, 2026, with a March 26, 2026 response deadline, seeking generic multi-source pharmaceuticals and OTC products for distribution across Minnesota, Oregon, and other participating jurisdictions through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), with contract performance penalties, cGMP and DSCSA compliance requirements, and a 3 percent administrative fee structure.